SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006822
Filing Date
2005-03-16
Accepted
2005-03-16 17:29:15
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2153359z10-k.htm 10-K 663170
2 EXHIBIT 3.6 a2153359zex-3_6.htm EX-3.6 4279
3 EXHIBIT 23.1 a2153359zex-23_1.htm EX-23.1 2282
4 EX-31.1 a2153359zex-31_1.htm EX-31.1 6087
5 EX-31.2 a2153359zex-31_2.htm EX-31.2 6104
6 EX-32 a2153359zex-32.htm EX-32 2695
  Complete submission text file 0001047469-05-006822.txt   686793
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 05686694
SIC: 2835 In Vitro & In Vivo Diagnostic Substances